NVO logo

Novo Nordisk A/S (NVO) return on equity

annual ROE:

82.01%-5.43%(-6.21%)
December 31, 2024

Summary

  • As of today (September 12, 2025), NVO annual return on equity is 82.01%, with the most recent change of -5.43% (-6.21%) on December 31, 2024.
  • During the last 3 years, NVO annual ROE has risen by +10.49% (+14.67%).
  • NVO annual ROE is now -6.21% below its all-time high of 87.44%, reached on December 31, 2023.

Performance

1-year change

-6.21%

3-year change

+14.67%

5-year change

+16.52%

15-year change

+2.53%

NVO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

93.03%
NVO annual return on equity is higher than 93.03% of companies in Healthcare sector

Range

All-time high

87.44%
NVO annual return on equity is currently -6.21% below its historical high of 87.44%

3-year low

68.81%
NVO annual return on equity is currently +19.18% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVOprofitability metrics

Annual revenue

$42.12B
NVO annual revenue is $42.12 billion

annual net income

$14.65B
NVO annual net profit is $14.65 billion

Annual EPS

$0.00
NVO annual earnings per share is $0.00

Annual ROA

26.32%
NVO annual return on assets is 26.32%

quarterly ROE:

80.40%-4.59%(-5.40%)
June 1, 2025

Summary

  • As of today (September 12, 2025), NVO quarterly return on equity is 80.40%, with the most recent change of -4.59% (-5.40%) on June 1, 2025.
  • Over the past year, NVO quarterly ROE has dropped by -9.23% (-10.30%).
  • NVO quarterly ROE is now -15.52% below its all-time high of 95.17%, reached on March 31, 2024.

Performance

3-month change

-5.4%

1-year change

-10.3%

3-year change

+9.4%

5-year change

+8.88%

NVO quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

91.77%
NVO quarterly return on equity is higher than 91.77% of companies in Healthcare sector

Range

All-time high

95.17%
NVO quarterly return on equity is currently -15.52% below its historical high of 95.17%

3-year low

73.49%
NVO quarterly return on equity is currently +9.40% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 1, 2025
NVO previous earnings announcement was published on Jun 1, 2025

Next quarterly earnings report date

Nov 5, 2025
NVO next earnings announcement is scheduled for Nov 5, 2025

OtherNVOprofitability metrics

Quarterly revenue

$11.68B
NVO quarterly revenue is $11.68 billion

quarterly net income

$4.03B
NVO quarterly net profit is $4.03 billion

Quarterly EPS

$0.00
NVO quarterly earnings per share is $0.00

Quarterly ROA

24.98%
NVO quarterly return on assets is 24.98%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

annual ROE

82.01%
NVO annual return on equity is 82.01%

annual net income

$14.65B
NVO annual net profit is $14.65 billion

annual shareholders equity

$19.92B
NVO annual stockholders equity is $19.92 billion

NVO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.2%-10.3%
3 y3 years+14.7%+9.4%
5 y5 years+16.5%+8.9%

NVO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.2%+19.2%-15.5%+9.4%
5 y5-year-6.2%+21.3%-15.5%+13.7%
alltimeall time-6.2%+781.8%-15.5%+1019.8%

NVO ROE History

DateAnnualQuarterly
Jun 2025
-
80.40%(-5.4%)
Mar 2025
-
84.99%(-2.2%)
Dec 2024
82.01%(-6.2%)
86.94%(-2.2%)
Sep 2024
-
88.86%(-0.9%)
Jun 2024
-
89.63%(-5.8%)
Mar 2024
-
95.17%(+3.3%)
Dec 2023
87.44%(+27.1%)
92.15%(+2.3%)
Sep 2023
-
90.04%(+8.8%)
Jun 2023
-
82.74%(+4.5%)
Mar 2023
-
79.17%(+7.4%)
Dec 2022
68.81%(-3.8%)
73.71%(-0.8%)
Sep 2022
-
74.27%(+1.1%)
Jun 2022
-
73.49%(-3.1%)
Mar 2022
-
75.85%(+2.2%)
Dec 2021
71.52%(+5.8%)
74.22%(-0.4%)
Sep 2021
-
74.53%(+1.6%)
Jun 2021
-
73.33%(+0.5%)
Mar 2021
-
72.93%(+3.2%)
Dec 2020
67.61%(-3.9%)
70.69%(-2.9%)
Sep 2020
-
72.77%(-1.4%)
Jun 2020
-
73.84%(-2.7%)
Mar 2020
-
75.87%(+2.7%)
Dec 2019
70.38%(-8.1%)
73.89%(-3.3%)
Sep 2019
-
76.40%(+1.8%)
Jun 2019
-
75.06%(-5.5%)
Mar 2019
-
79.47%(-0.6%)
Dec 2018
76.55%(-4.3%)
79.98%(-1.4%)
Sep 2018
-
81.08%(-2.0%)
Jun 2018
-
82.77%(-2.2%)
Mar 2018
-
84.63%(+2.9%)
Dec 2017
79.99%(-5.9%)
82.21%(-4.4%)
Sep 2017
-
85.96%(-2.1%)
Jun 2017
-
87.76%(-6.0%)
Mar 2017
-
93.38%(+4.5%)
Dec 2016
85.00%(+9.8%)
89.37%(+1.0%)
Sep 2016
-
88.52%(+2.8%)
Jun 2016
-
86.09%(-0.5%)
Mar 2016
-
86.50%(+1.0%)
Dec 2015
77.44%(+18.4%)
85.62%(+1.0%)
Sep 2015
-
84.81%(+2.8%)
Jun 2015
-
82.48%(+0.2%)
Mar 2015
-
82.30%(+17.8%)
Dec 2014
65.40%(+9.7%)
69.89%(+1.5%)
Sep 2014
-
68.89%(-0.5%)
Jun 2014
-
69.21%(-0.4%)
Mar 2014
-
69.52%(+5.9%)
Dec 2013
59.61%(+10.6%)
65.66%(-2.8%)
Sep 2013
-
67.52%(-1.2%)
Jun 2013
-
68.32%(+5.3%)
Mar 2013
-
64.90%(+8.9%)
Dec 2012
53.91%(+11.5%)
59.59%(+1.6%)
Sep 2012
-
58.64%(+8.2%)
Jun 2012
-
54.22%(+8.0%)
Mar 2012
-
50.19%(+5.0%)
Dec 2011
48.37%(+28.0%)
47.78%(+3.5%)
Sep 2011
-
46.18%(+3.3%)
Jun 2011
-
44.71%(+3.1%)
Mar 2011
-
43.35%(+6.0%)
Dec 2010
37.79%(+22.6%)
40.89%(+11.8%)
Sep 2010
-
36.56%(+4.7%)
Jun 2010
-
34.93%(+2.9%)
Mar 2010
-
33.95%(+7.8%)
Dec 2009
30.82%(+1.5%)
31.48%(-0.2%)
Sep 2009
-
31.53%(+0.1%)
Jun 2009
-
31.51%(+2.2%)
Mar 2009
-
30.82%(+4.1%)
Dec 2008
30.36%(+12.9%)
29.60%(+13.8%)
Sep 2008
-
26.01%(+8.6%)
Jun 2008
-
23.94%(-13.3%)
Mar 2008
-
27.60%(+4.2%)
Dec 2007
26.90%(+20.1%)
26.49%(-11.3%)
Sep 2007
-
29.87%(+1.2%)
Jun 2007
-
29.52%(+22.3%)
Mar 2007
-
24.13%(+5.6%)
Dec 2006
22.39%(+5.5%)
22.86%(+6.1%)
Sep 2006
-
21.54%(-1.1%)
Jun 2006
-
21.79%(-1.1%)
Mar 2006
-
22.04%(-0.2%)
Dec 2005
21.22%(+15.5%)
22.08%(-6.5%)
Sep 2005
-
23.62%(+7.8%)
Jun 2005
-
21.91%(+8.0%)
Mar 2005
-
20.29%(+3.7%)
DateAnnualQuarterly
Dec 2004
18.37%(-6.6%)
19.56%(-0.4%)
Sep 2004
-
19.64%(+0.4%)
Jun 2004
-
19.57%(-3.0%)
Mar 2004
-
20.18%(-1.4%)
Dec 2003
19.67%(+7.0%)
20.47%(+0.5%)
Sep 2003
-
20.37%(-0.0%)
Jun 2003
-
20.38%(+1.7%)
Mar 2003
-
20.03%(+5.0%)
Dec 2002
18.39%(-13.0%)
19.07%(+0.1%)
Sep 2002
-
19.06%(-3.3%)
Jun 2002
-
19.71%(-0.2%)
Mar 2002
-
19.75%(-9.1%)
Dec 2001
21.13%(+24.3%)
21.73%(+8.2%)
Sep 2001
-
20.08%(+32.7%)
Jun 2001
-
15.13%(+51.5%)
Mar 2001
-
9.99%(-50.4%)
Dec 2000
17.00%(+31.6%)
20.16%(+180.8%)
Mar 2000
-
7.18%(-46.9%)
Dec 1999
12.92%(-1.6%)
13.53%(+38.3%)
Sep 1999
-
9.78%(-25.5%)
Jun 1999
-
13.12%(+0.5%)
Mar 1999
-
13.05%(-10.5%)
Dec 1998
13.13%(+4.4%)
14.58%(+2.2%)
Sep 1998
-
14.26%(+0.8%)
Jun 1998
-
14.14%(+6.6%)
Mar 1998
-
13.27%(-4.7%)
Dec 1997
12.58%(+7.2%)
13.93%(+20.1%)
Sep 1997
-
11.60%(+1.8%)
Jun 1997
-
11.39%(+1.8%)
Mar 1997
-
11.19%(-21.0%)
Dec 1996
11.74%(-0.6%)
14.16%(+25.2%)
Sep 1996
-
11.31%(+0.5%)
Jun 1996
-
11.25%(-1.0%)
Mar 1996
-
11.36%(-19.5%)
Dec 1995
11.81%(+1.7%)
14.11%(+3.1%)
Sep 1995
-
13.69%(+6.2%)
Jun 1995
-
12.89%(+16.1%)
Mar 1995
-
11.10%(-17.5%)
Dec 1994
11.61%(-10.0%)
13.46%(+14.1%)
Sep 1994
-
11.80%(+0.9%)
Jun 1994
-
11.70%(-2.0%)
Mar 1994
-
11.94%(-20.5%)
Dec 1993
12.90%(-0.6%)
15.02%(+15.3%)
Sep 1993
-
13.03%(+10.1%)
Jun 1993
-
11.84%(-3.1%)
Mar 1993
-
12.22%(-27.8%)
Dec 1992
12.98%(+25.2%)
16.92%(+53.1%)
Sep 1992
-
11.05%(0.0%)
Jun 1992
-
11.05%(+12.9%)
Mar 1992
-
9.79%(-27.4%)
Dec 1991
10.37%(-9.2%)
13.48%(+14.8%)
Sep 1991
-
11.74%(+6.4%)
Jun 1991
-
11.03%(+1.7%)
Mar 1991
-
10.85%(-22.8%)
Dec 1990
11.42%(-2.2%)
14.05%(+17.9%)
Sep 1990
-
11.92%(+4.7%)
Jun 1990
-
11.38%(+11.9%)
Mar 1990
-
10.17%(-26.5%)
Dec 1989
11.68%(+1.8%)
13.83%(+9.6%)
Sep 1989
-
12.62%(+7.0%)
Jun 1989
-
11.79%(-11.9%)
Mar 1989
-
13.38%(-10.1%)
Dec 1988
11.47%(+23.3%)
14.89%(+27.7%)
Sep 1988
-
11.66%(+2.9%)
Jun 1988
-
11.33%(+24.1%)
Mar 1988
-
9.13%(-25.5%)
Dec 1987
9.30%(-11.3%)
12.25%(+1.3%)
Sep 1987
-
12.09%(+0.5%)
Jun 1987
-
12.03%(-2.5%)
Mar 1987
-
12.34%(-5.0%)
Dec 1986
10.48%(-13.5%)
12.99%(+19.4%)
Sep 1986
-
10.88%(+3.6%)
Jun 1986
-
10.50%(+3.3%)
Mar 1986
-
10.16%(-2.4%)
Dec 1985
12.12%(-28.6%)
10.41%(-33.1%)
Sep 1985
-
15.55%(-3.8%)
Jun 1985
-
16.17%(-2.9%)
Mar 1985
-
16.66%(-1.2%)
Dec 1984
16.97%(-26.2%)
16.87%
Dec 1983
22.99%(-11.3%)
-
Dec 1982
25.91%(+9.8%)
-
Dec 1981
23.59%(+20.4%)
-
Dec 1980
19.59%
-

FAQ

  • What is Novo Nordisk A/S annual return on equity?
  • What is the all time high annual ROE for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual ROE year-on-year change?
  • What is Novo Nordisk A/S quarterly return on equity?
  • What is the all time high quarterly ROE for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly ROE year-on-year change?

What is Novo Nordisk A/S annual return on equity?

The current annual ROE of NVO is 82.01%

What is the all time high annual ROE for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual return on equity is 87.44%

What is Novo Nordisk A/S annual ROE year-on-year change?

Over the past year, NVO annual return on equity has changed by -5.43% (-6.21%)

What is Novo Nordisk A/S quarterly return on equity?

The current quarterly ROE of NVO is 80.40%

What is the all time high quarterly ROE for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly return on equity is 95.17%

What is Novo Nordisk A/S quarterly ROE year-on-year change?

Over the past year, NVO quarterly return on equity has changed by -9.23% (-10.30%)
On this page